2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Severe Hypertriglyceridemia: new trials by email Literature Review of Severe Hypertriglyceridemia trials Research Report on Severe Hypertriglyceridemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Tolerability and Efficacy of ION775 ION775 - Hypertriglyceridemia, Severe Hypertriglyceridemia | Phase 2 | Recruiting | Ionis Pharmaceuticals, Inc. | 72 | 2026-05-12 | 2026-11-02 |
| A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia Solbinsiran, Placebo - Severe Hypertriglyceridemia | Phase 2 | Recruiting | Eli Lilly and Company | 60 | 2025-12-08 | 2026-11-04 |
Dyslipidemias (2) · Hyperlipidemias (2) · Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Eli Lilly and Company (1) · Ionis Pharmaceuticals, Inc. (1)
Canada (2) · United States (2) · China (1) · Japan (1)